Introduction
The mucopolysaccharidoses (MPS) are a group of heritable lysosomal storage disorders caused by a deficiency in glycosaminoglycan (GAG)-degrading enzymes. The resulting accumulation of unprocessed or partly processed GAGs-dermatan sulphate, heparan sulphate, keratan sulphate and chondroitin sulphate-in lysosomes causes progressive damage of affected tissues, including heart, respiratory system, bones, joints and central nervous system [1] . Seven distinct clinical types of MPS have been identified and described in the literature, caused by 11 different enzymatic deficiencies. Even if each type of MPS presents a rare incidence, the overall incidence is not negligible (1 in 25,000 live births). Transmission occurs in an autosomal recessive fashion, except for MPS II, which is X-linked [2] .
The ubiquitous nature of GAGs within the connective tissue of the body results in a wide range of clinical effects. The type of GAGs stored and the classification of disease depend on the specific enzyme deficiency [3] . Table 1 outlines the latest classification, with details of the accumulating compounds and enzymes deficiencies, as well as the eponym used for each condition.
Like most genetic disorders, there is a continuous spectrum of phenotype from the very severe to the most mildly affected; many mutations are responsible for these phenotypic differences [2] . The typical symptoms, encountered in the majority of MPS, include organomegaly, dysostosis multiplex, mental retardation and developmental delay. Otological (otitis media) and respiratory (airway obstruction) problems can also be present. Other manifestations include impaired vision (corneal clouding and photophobia) [4] and cardiovascular involvement (myocardial hypertrophy, systolic dysfunction and valve dysfunction) [5] [6] [7] .
The course of MPS is variable from very severe forms, with an average expected life span of 1 or 2 decades (neuronopathic forms in particular are usually fatal diseases) to attenuated or slowly progressing ones that allow the patient to reach adulthood [1, 3, 8] .
A combination of clinical picture and analysis of urinary GAGs is usually performed to achieve the diagnosis of MPS, even though this method cannot recognise subtypes; definitive diagnosis is usually possible through measuring enzyme activity in cultured fibroblasts or leukocytes [1, 2] .
Treatment consists mainly of symptomatic and supportive care, including decompression of the craniocervical narrowing, tracheostomy insertion and corneal transplantat i on . I n r ec e nt y e ar s t h e d ev e l o pm en t o f n ew therapies-represented by enzyme replacement therapies, substrate inhibition therapy and haematopoietic cell transplantation-have changed the treatment of these patients, with a fundamental shift in the approach from symptomatic management to therapeutic intervention; in many cases, the introduction of these new therapies has significantly improved the duration and quality of life for patients [9, 10] . 
Imaging findings
In patients with MPS, radiological and neuroradiological imaging findings have been described [11] . The most important radiological findings occur in the skeletal system with multiplex dysostosis (Table 2) , a complex of anomalies involving several bones [12] [13] [14] , dominating the clinical picture in MPS IV and MPS VI.
The abnormal storage of GAG in the mouth, nose, pharynx and larynx results in several otorhinolaryngological disorders; in view of this, otorhinolaryngological imaging findings have been described. Patients can also show hepatomegaly and splenomegaly.
Regarding neuroradiological features, the involvement of the central nervous system is predominant in MPS I, II, III and MPS VII [15, 16] .
In this pictorial review we focus on skeletal, otorhinolaryngological and neuroradiological imaging findings encountered in patients with MPS. 
Skeletal imaging findings

Axial skeleton
The most important radiological findings in the axial skeleton regard the skull, thorax, spine and pelvis.
The skull is often characterised by an abnormal "Jshaped" conformation of the sella turcica, seen on the lateral view of the cranium (Fig. 1) . The sella turcica is normally a saddle-shaped depression in the sphenoid bone, while in MPS patients it is usually wide with long clinoid apophyses and horizontal orientation: the tuberculum sellae is flattened and the dorsum sellae is rounded, respectively, forming the straight edge and the loop of the "J". This configuration may represent a normal anatomic variant and may be associated with neurofibromatosis or with a slow-growing tumour adjacent to the sella, such as an optic chiasm glioma, so the "Jshaped" sella turcica is characteristic, but not diagnostic of mucopolysaccharidosis.
The cortical bone of the skull is thickened. The premature closure of the sagittal suture is responsible for the development of macrocephaly with dolicocephaly, plus the metopic perisutural hyperostosis causes a vertical frontal crest. The most important facial anomalies are represented by the lack of pneumatization of mastoid cells and paranasal cavities; the mandible is short and broad, mandibular condyles are undeveloped and the temporomandibolar joint may exhibit limited motion; unerupted and widely spaced teeth can also be found (Fig. 1) .
Concerning the thorax, the main abnormality concerns the ribs, which can be "paddle-shaped" or "oar-shaped" because of the widening of the anterior archs and of the tapering of the posterior ones. Other common modifications are small scapulae, usually with flattening of the glenoid Fig. 3 Spine abnormality. Sagittal T2-weighted fast spinecho image (a); sagittal T1-weighted fast spin-echo image (b). The figures show the entire spine of a 14-year-old female with MPS VI: narrowing of the craniocervical junction (white arrow), vertebral bodies deformities (curved white arrow) and nucleus pulposus hypotrophy (white arrowhead) are well depicted; gibbus at thoracolumbar region is also seen Fig. 2 Thoracic abnormality. Frontal radiographs showing a normal chest in a 10-year-old girl (a) and a chest of a 10-yearold girl affected by MPS IV (b), the latter presenting ribs (white arrowheads) tapered proximally and wider distally; broad and short clavicles (white arrow) can be seen in the magnified view of the clavicles (c) cavities, a short sternum and short and thickened aspect of the clavicles ( Modifications of the shape of vertebral bodies are very common, resulting in flattened and rounded vertebrae ( Fig. 5) . At the thoraco-lumbar level the vertebral body can show a deficiency in its anterosuperior corner and, as a consequence, an apparent prolongation of the anteroinferior one, resulting on the lateral X-ray in an "anterior beaking" aspect. When hypoplasia of both anterior corners occurs, the vertebral body is wedge-shaped. These vertebral morphologic changes may progressively evolve to gibbus deformity (Fig. 6 ), particularly in MPS I. Scoliosis is usually not bad enough to require surgery; however, myelopathy can represent an indication of the need for surgical treatment [12] .
The most common radiological features in the pelvis are rounded iliac wings and inferior tapering of the ileum (Fig. 7) [18] . The alterations of the hip joint can lead to hip dysplasia because of the poor development of the acetabulum and the underdevelopment of the medial portion of the proximal femoral epiphysis. This alteration has not been shown to respond to medical therapy, so for these children surgical reconstruction is often required; the target of this treatment is the optimisation of hip mechanics [12] .
Peripheral skeleton
In MPS patients, the long bones are often characterised by several alterations. Diaphyses are shortened and curved in the distal part; the epiphyses are slightly hypoplastic and thinned cortically with osteoporosis [15] . Other features that can be found are the notching of the proximal part of the humerus, the long and narrow aspect of the femoral neck (Fig. 8) , and the hypoplasia of the lateral tibial hemiplate, resulting in genu valgum.
Knees can also be involved, particularly in children with MPS IV and MPS I, developing genu valgum (Fig. 9 ). This condition is sometimes severe enough to require surgery. In adulthood an advanced state of arthrosis can be recognised because of the considerable delamination of articular cartilage. These patients are potential surgical candidates for total knee arthroplasty [12] .
On MRI images, the growth plate is irregularly enlarged, with multiple defects and erosions well depicted on coronal fast spin-echo proton-density-weighted images (Fig. 10) .
Almost all forms of MPS show distortion of the hand (Fig. 11) and foot structure. Carpal and tarsal bones are hypoplastic and irregularly shaped; the metacarpal bones are proximally pointed, shortened and thickened. The functionality of the fingers is compromised because of the bone alterations and the thickening of the subcutaneous tissues, resulting in a failure of a complete extension of the fingers with a "claw hand" deformity [19, 20] .
Distal ulna and radius can be hypoplastic and have a "Vshaped" appearance; this oblique deformity of the terminal part of both bones results in the alteration of the carpal angle. The alterations in the skeletal anatomy, combined with an excessive GAG deposition in the connective tissue, cause the constriction of the median nerve resulting in carpal tunnel syndrome [21] .
Otorhinolaryngological imaging findings
Abnormal secretions and infiltration of GAG in the mouth, nose, pharynx and larynx result in several otorhinolaryngological manifestations, sometimes the first to appear [22] ; 
ear, nose, throat and respiratory disorders are very common. The most important otorhinolaryngological problems are rhinitis, otitis media, and upper and lower airway obstruction [23] .
Upper airway obstruction may be the consequence of macroglossia, adenotonsillar hypertrophy and chronic nasal discharge in combination with a decreased temporo-mandibular joint mobility. Eustachian tube dysfunction due to enlarged adenoids and inflammation as a consequence of abnormal storage of GAG in the temporal bone are responsible for chronic otitis media and conductive hearing loss [24] . A thickened, retracted tympanic membrane and an increased attenuation of the tympanic cavity and mastoid cells can be observed on multidetector computed tomography (MDCT) images (Fig. 12) [25] . Hearing impairment can also have a sensorineural component because of GAG deposition in the inner ear or central nervous system. The surgical removal of the tonsils and adenoids is often required, even though it is only a temporary solution.
Lower airway obstruction, due to tracheomalacia and narrowing of the tracheal lumen, may lead to pneumonia and acute respiratory insufficiency. The radiologist should know that multiplanar reconstruction of a MDCT scan, usually performed in these patients for the evaluation of the atlanto-axial instability, may be an important tool to On corresponding T2-weighted FLAIR images (c and d), these areas (white arrow and white arrowhead) are hypointense. This typical imaging described in the brain of patients with MPS is the "honeycomb-like" appearance. Note also ventriculomegaly and diffuse high signal intensity in the periventricular white matter assess the status of the whole airway passage. Anaesthesiologists could use this information to improve their preoperative airway management [26] [27] [28] . Sometimes it may be necessary to perform a tracheostomy in order to ensure airway safety [24, 29] .
Neuroradiological imaging findings
The pathogenetic substrate of central nervous system involvement lies in the abnormal accumulation of Despite encouraging results observed in patients with MPS II, the ERT therapy does not seem to improve the appearance of neuroradiological imaging findings; the enzymes do not cross the haematoencephalic barrier. However, new evidence is needed in order to investigate the progression of neuroradiological imaging findings after treatment mucopolysaccharides within perivascular spaces and neuroaxonal units with an adversely affected myelin turnover [30] .
On the basis of MRI findings a large spectrum of severity can be recognised, from negligible to severe. Here we describe the main neuroradiological features: abnormal signal intensity in the white matter and in the basal ganglia, dilatation of periventricular spaces, widening of cortical sulci, brain atrophy and enlargement of extraventricular spaces, and spinal cord compression. Recently, a few cases of closed cephalocele have been reported in the literature [31] .
Abnormal signal intensity in the white matter and in the basal ganglia One of the typical neuroradiological imaging findings is represented by focal or diffuse white matter lesions, detected as areas of high signal intensity on T2-weighted sequences. These alterations show an increase with aging, becoming more extensive with time.
Diffuse white matter lesions usually show a symmetrical periventricular distribution, although they can also be found as patchy lesions in the subcortical region (Fig. 13) . They derive from the delay of myelination in young children and progressive demyelination in the course of the disease; these lesions can also reflect gliosis [32, 33] . Focal white matter lesions consist of multiple small spot-like areas isointense to the cerebrospinal fluid (CSF) on fluid attenuated inversion recovery (FLAIR), T2-weighted and T1-weighted sequences (Fig. 14) because of periventricular space enlargement.
The corpus callosum, best depicted on sagittal images, is sometimes the only location of these lesions, although they can also be encountered in the parietal and occipital lobe, in the basal ganglia, in the thalamus and at the grey-white matter junction level [32] [33] [34] . A typical imaging feature in the brain of patients with MPS is the "honeycomb-like" appearance in the basal ganglia and thalami (Fig. 15) ; this imaging finding has been observed in patients with MPS I, II and IIIB [35, 36] . Two theories have been proposed to explain the pathogenesis of basal ganglia involvement; the first concerns the accumulation of GAGs in neurons and astrocytes, leading to neuronal loss and demyelination; another theory maintains that the basal ganglia appearance could be related to an increase of fluid content in the periventricular spaces.
The pathogenesis of enlargement of perivascular spaces is not entirely clear [34] . Two main hypotheses have been formulated: accumulation of GAG around vessels [37] and impairment of cerebrospinal fluid reabsorption (caused by the deposit of mucopolysaccharides in the leptomeninges) [32] .
In addition, in the white matter of parietal and occipital lobes, multifocal variable-sized areas of high signal intensity-which doesn't match that of cerebrospinal fluid-may be detected on FLAIR and T2-weighted sequences; these lesions, probably due to gliosis, tend to become extensive and confluent.
Hydrocephalus and brain atrophy
Ventricular enlargement, with or without involvement of the subarachnoid spaces, is a common finding in patients with MPS (Figs. 13, 14, 15, 16 and 17) . Communicating hydrocephalus may be the consequence of either diffuse brain atrophy or reabsorption failure of cerebrospinal fluid due to dysfunction of the arachnoid granulations. A cysticappearing enlargement of the cerebellomedullary and/or suprasellar cisterna has been described [34] .
The atrophy of the brain, probably due to neuronal death and myelin loss, is a common feature in MPS and is seen as widened subarachnoid spaces and enlargement of the Fig. 19 Involvement of the craniocervical junction: recurrence after surgery. Craniocervical junction appearance in an MPS VI patient before (a) and after (a") the decompressive surgical procedure: note the improvement in size of the craniocervical junction, with enlargement of subarachnoid spaces after the surgical procedure. b and b" show recurrence of stenosis of the craniocervical junction in an MPS IV patient 3 and 12 years respectively after surgery; the recurrence is due to progression of GAG accumulation cortical sulci. The neuronal death could be explained by ischaemic damages due to the progressive accumulation of GAG in blood vessels [38] ; on the other hand, the neuronal death could be caused by direct intracellular storage of GAG.
The MRI evaluation of these findings is a useful marker of axonal loss [16] . Brain atrophy usually develops earlier in MPS I, II, III and VII, becoming visible during the first few years of life; on the contrary, patients with MPS IV and VI typically have normal intelligence and don't show signs of atrophy until the second decade of life.
The different degree of brain atrophy has been recently evaluated for monitoring disease progression and response to therapy [15, 33] ; these authors reported a classification using the method introduced by Lee et al. [38] . Brain atrophy could be: A strong correlation was found between severity of brain atrophy and cognitive impairment in MPS [33, 39] , whereas other authors did not find the same correlation [40] .
Spinal cord compression
Compression of the spinal cord most frequently occurs at the atlanto-axial (C1-C2) joint (Figs. 18 and 19) , especially affecting patients with MPS IV and VI. Many of these patients suffer from several craniocervical junction abnormalities due to structural defects involving the spine. The most important one is atlanto-axial subluxation, which is the result of several causes: laxity of the transverse ligament, dural thickening resulting from deposition of collagen and GAGs, hypoplasia or absence of the odontoid, anterior soft tissue mass of the odontoid (representing a combination of unossified fibrocartilage and reactive changes) and indentation of the posterior arch of C1 [33] . The anomaly of the odontoid process ranges in severity from total aplasia to a triangular-shaped configuration with a loss in vertical height and a broad-based tip [41] . Chronic subluxation of the C1-C2 level may lead to a ligamentous hypertrophy and to further narrowing in the region of the craniocervical junction with the consequence of additional cord compression. Another cause of cord compression in these patients is gibbous formation in the thoracic spine, resulting from the malformations of vertebral bodies (most common in Morquio disease). Compressive cervical myelopathy is a critical problem since the involvement of the bulbar-spine junction may lead to central respiratory failure [33] .
Magnetic resonance spectroscopy (MRS)
MRS (Fig. 20) is a non-invasive imaging technique able to provide information about tissue molecular structures. Brain application leads to revealing the concentration of brain metabolites and can be used to monitor biochemical changes in brain diseases.
Numerous studies have suggested a contribution of MRS to mucopolysaccharidoses assessment [42, 43] .
Davison et al. [42, 43] found a reduction of the white matter N-acetylaspartate/creatine (NAA/Cr) ratio in MPS IVa and II proportional to cognitive indices and to disease progression [42, 43] , while Vedolin did not find a significant difference in the NAA/Cr ratio between patients with and without cognitive impairment; Vedolin found instead an elevated myo-inositol/creatine (mIns/Cr) ratio in patients with cognitive impairment [39] . The increase in the mIns/Cr ratio is interpreted as a possible marker of glial activity (Fig. 20) .
Takahashi et al. [44] measured presumptive mucopolysaccharides in white matter lesions and in white matter without lesions and compared the presumptive MPS/Cr ratios before and after bone marrow transplantation (BMT) [44] . They found a reduction in mucopolysaccharides in white matter without lesions after the BMT; they also found a correlation between mucopolysaccharide accumulation and neuronal damage resulting in a decreased NAA/Cr ratio [44] .
In summary, new evidence is needed in order to understand the real value of MRS in the evaluation of neurological involvement.
Miscellaneous
Another commonly found sign in MPS patients is macrocephaly, resulting from hydrocephalus combined with abnormal accumulation of incompletely broken down GAGs within the brain, meninges and skull. Macrocephaly is diagnosed when the circumference of the head exceeds normal values by more than two standard deviations. Other dysmorphic features, such as frontal prominence, scaphocephaly, a short neck and enlarged tongue, can be observed.
Several orbital abnormalities can be found: thickening of the sclera and of the optic nerve sheath, optic canal narrowing and optic nerve atrophy (Fig. 21) .
Finally, another imaging features reported in literature [31] is the closed encephalocele (Figs. 22 and 23) ; regarding this point, the presence of parenchymal/meningeal herniation at the level of the anterior or middle cranial fossa has been described as a characteristic neuroradiological feature of patients affected by MPS II. Instead of the term "meningoencephalocele," which indicates the herniation of brain and/or meningeal tissue through a bone defect, the term "closed cephalocele" has been proposed to describe this skull abnormality because the protrusion of intracranial structures occurs without a detectable bone defect. The etiopathogenesis of this further manifestation seems to be related to an increased intracranial pressure and/or an altered bone maturation process. CT and MRI reveal a variablesized pouch filled with brain parenchyma and cerebrospinal fluid, delimited by a bone wall and usually located in the anterior cranial fossa at the level of the lamina cribrosa as a weak area of the skull. The radiologist should look out for the presence of a closed cephalocele because it may interfere with rhinosurgery and cause epilepsy [31] .
Conclusion
Knowledge of radiological and neuroradiological appearances of MPS is essential for radiologists. Skeletal X-ray and MRI may show specific features in MPS patients, although it is not possible to accurately differentiate between MPS types based on skeletal and neurological characteristics. The evaluation of these imaging findings is useful for suggesting and supporting MPS as a possible diagnosis, usually obtained by laboratory analysis, for monitoring the chronic and progressive course of the disease, for surgical and medical planning and for assessing the impact of therapy.
